Human non-interferon macrophage activating factor: biological and biochemical characterization

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Human T-cell leukemia virus type 1 (HTLV-1) can transform T cells.
• Activated T cells secrete various lymphokines that modulate immune responses.
• Identifying novel immune-modulating factors is crucial for therapeutic development.

Purpose of the Study:

• To characterize a novel lymphokine produced by HTLV-1 transformed T cells.
• To determine the biological and biochemical properties of this lymphokine.
• To evaluate its potential therapeutic applications in immune-compromised hosts.

Main Methods:

• Establishment and culture of HTLV-1 transformed T cell lines.
• Partial purification of secreted lymphokine.
• In vitro assays to assess effects on human monocyte function (microbicidal and tumoricidal activities).
• Biochemical characterization including molecular weight and isoelectric point determination.

Main Results:

• A novel lymphokine with macrophage-activating properties was identified.
• This lymphokine is distinct from known cytokines like interferon-gamma, interleukins, and lymphotoxin.
• Treatment of human monocytes with the lymphokine induced significant microbicidal and tumoricidal activities.
• The active protein component has an estimated molecular weight of 55,000 daltons and an isoelectric point of 5.5.

Conclusions:

• A novel lymphokine with potent macrophage-activating capabilities has been discovered.
• This lymphokine demonstrates potential for enhancing host defense mechanisms.
• It holds promise for the therapeutic intervention against opportunistic infections in immunocompromised patients.